Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Kedra

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Joint Bone Spine|March 6, 2022
National reimbursement databases: Use and limitations for rheumatologic studiesJoanna Kedra, Bruno Fautrel
Joint Bone Spine|September 15, 2019
Big Data and artificial intelligence: Will they change our practice?Joanna Kedra, Laure Gossec
Joint Bone Spine|February 26, 2023
Cancer screening in chronic inflammatory rheumatic diseasesJoanna Kedra, Raphaèle Seror
Zeitschrift Fur Rheumatologie|October 11, 2021
Wearable activity trackers and artificial intelligence in the management of rheumatic diseases : Where are we in 2021?Thomas Davergne, Joanna Kedra, Laure Gossec
Joint Bone Spine|March 27, 2021
Inflammation-targeted therapies and cancerJoanna Kedra, Gaetane Nocturne, Xavier Mariette, et al.
Expert Review of Clinical Immunology|December 10, 2021
Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directionsJoanna Kedra, Thomas Davergne, Ben Braithwaite, et al.
Joint Bone Spine|April 2, 2017
Lewis-Sumner syndrome in a patient with rheumatoid arthritis: Link between rheumatoid arthritis and demyelinating polyradiculoneuropathiesJoanna Kedra, Violaine Foltz, Karine Viala, et al.
RMD Open|May 9, 2022
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohortJoanna Kedra, Alexandre Lafourcade, Bernard Combe, et al.
Presse Medicale (Paris, France : 1983)|March 18, 2019
Fatigue after a corticosteroid joint injectionJoanna Kedra, Sophie Godot, Pascal Chazerain, et al.
Joint Bone Spine|August 7, 2020
Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIRJoanna Kedra, Benjamin Granger, Stéphanie Emilie, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Joint Bone Spine|March 6, 2022
National reimbursement databases: Use and limitations for rheumatologic studiesJoanna Kedra, Bruno Fautrel
Joint Bone Spine|September 15, 2019
Big Data and artificial intelligence: Will they change our practice?Joanna Kedra, Laure Gossec
Joint Bone Spine|February 26, 2023
Cancer screening in chronic inflammatory rheumatic diseasesJoanna Kedra, Raphaèle Seror
Zeitschrift Fur Rheumatologie|October 11, 2021
Wearable activity trackers and artificial intelligence in the management of rheumatic diseases : Where are we in 2021?Thomas Davergne, Joanna Kedra, Laure Gossec
Joint Bone Spine|March 27, 2021
Inflammation-targeted therapies and cancerJoanna Kedra, Gaetane Nocturne, Xavier Mariette, et al.
Expert Review of Clinical Immunology|December 10, 2021
Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directionsJoanna Kedra, Thomas Davergne, Ben Braithwaite, et al.
Joint Bone Spine|April 2, 2017
Lewis-Sumner syndrome in a patient with rheumatoid arthritis: Link between rheumatoid arthritis and demyelinating polyradiculoneuropathiesJoanna Kedra, Violaine Foltz, Karine Viala, et al.
RMD Open|May 9, 2022
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohortJoanna Kedra, Alexandre Lafourcade, Bernard Combe, et al.
Presse Medicale (Paris, France : 1983)|March 18, 2019
Fatigue after a corticosteroid joint injectionJoanna Kedra, Sophie Godot, Pascal Chazerain, et al.
Joint Bone Spine|August 7, 2020
Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIRJoanna Kedra, Benjamin Granger, Stéphanie Emilie, et al.
Pageof 3